ACCRUED EXPENSES AND OTHER LIABILITIES (Details)	Jun. 30, 2014 USD ($)	Dec. 31, 2013 USD ($)	Jun. 30, 2014 ProteoSys USD ($)	Jun. 30, 2014 ProteoSys EUR (€)	Jun. 30, 2014 ProteoSys Minimum USD ($)
Accrued expenses and other liabilities
Research and development costs	$ 350,784	$ 58,117
Professional fees	210,000	595,215
Expenses due to related parties	177,230	126,910
Interest payable	114,429	24,276
Vacation pay	26,090	5,690
Bonus	486,000
ProteoSys milestone payable			682,250	500,000
Primomed research funding	236,294
Consulting and other costs	55,388	5,031
Accrued expenses and other liabilities	2,338,465	815,239
Cost incurred in connection with the preparation of a public offering of the Company's common stock included in accrued professional fees	200,000	400,000
Equity financing obligation					$ 5,000,000